Paige, a digital pathology diagnostics company, has received De Novo marketing authorization from the Food and Drug Administration for its artificial intelligence software that helps detect prostate cancer.
The Paige Prostate software analyzes digitized biopsy slides and identifies areas that could be cancerous for the pathologist to review further.
“The approval is a landmark achievement in the...
Inspiration4, an all-civilian commercial space mission that aims to launch in mid-September, will be conducting a variety of experiments to test the impact of spaceflight on the body.
SpaceX, the Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine and researchers at Weill Cornell Medicine will collect environmental and biomedical data, as well as biological...
Israeli sleep apnea company Itamar Medical announced today it’s broadening the capabilities of its at-home sleep apnea diagnostic testing line, WatchPAT.
The WatchPAT system attaches to a user’s index finger, chest and wrist to record vital measurements that are used to identify events of sleep apnea. It measures peripheral arterial (PAT) signal, heart rate, oximetry, actigraphy, body position,...
Pediatric behavioral health company Cognoa has received FDA De Novo classification for its autism spectrum disorder (ASD) software diagnostic aid, Canvas Dx.
The ASD diagnostic tool is designed to help primary care clinicians and pediatricians evaluate and diagnose suspected cases of autism among children. It uses machine learning algorithms to analyze videos of the child’s behavior and responses...
Ibex Medical Analytics, an Israel-based startup using artificial intelligence to support cancer diagnostics, has unveiled a $38 million Series B funding round. Octopus Ventures and 83North led the raise, which also saw participation from aMoon, Planven Entrepreneur Ventures and Dell Technologies Capital.
WHAT IT DOES
Ibex's Galen platform uses AI and machine learning to reduce the burden on...
.jpg?itok=hrNKefFL)
